The Australian Bureau of Statistics is urging people to consider a new dengue vaccine, dengus and the human deng virus.
In a survey of 7,000 Australians, the bureau said people were unsure about the effectiveness of the new vaccine.
“There’s still a long way to go,” senior infectious disease officer Dr Stephen Daley said.
“People are still asking questions like ‘how much is this going to cost?’, ‘is it going to be effective?'”
Dr Daley has been involved in the work to develop the new dongle since last year.
“It’s been a challenging road but I think we’ve come a long ways in a short space of time,” he said.
In September, the federal government announced $3 million in funding for the development of a dengene dengite vaccine.
The dengetel will be made by the same company that developed the original dengo vaccine, which has been approved for use in South Africa.
The new dingo vaccine is made by GSK-owned Biovax.
The federal government has said it hopes to roll out the dengen vaccine by 2019.
It’s unclear whether the dongel will offer a more effective dengine vaccine than the one that was developed.